CNS SPECTRUMS

Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)

Reward systems and cognitions in Major Depressive Disorder.

Cognitive impairment in major depressive disorder.

Cognition, social cognition, and Self-assessment in schizophrenia: prediction of different elements of everyday functional outcomes.

Neuronal underpinnings of cognitive impairment and - improvement in mood disorders.

Compulsivity is measurable across distinct psychiatric symptom domains and is associated with familial risk and reward-related attentional capture

The role of dopamine D3 receptors in the mechanism of action of cariprazine.

A study on the correlates of habit-, reward-, and fear-related motivations in alcohol use disorder.

A different aspect of the unexpected death of Mozart at the age of 35 years.

Emotional distress, brain functioning, and biobehavioral processes in cancer patients: a neuroimaging review and future directions.

Conducting clinical studies targeting cognition in psychiatry: guiding principles and design.

Altered brain functional networks in Internet gaming disorder: independent component and graph theoretical analysis under a probability discounting task.

50 Adjunctive Buprenorphine/Samidorphan Combination in Patients with Major Depressive Disorder: Phase 3 Long-term Extension Study Results.

Decriminalizing mental illness: specialized policing responses.

Neurocognition and social cognition training as treatments for violence and aggression in people with severe mental illness.

45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study.

64 Aripiprazole Long-acting Injectable in Schizophrenia. An 18-month Follow-up and Mirror-image Study.

Keeping Up with Clinical Advances: Opioid Use Disorder.

27 A New Method for Initiating Treatment with the Long-acting Antipsychotic Aripiprazole Lauroxil.

95 Differential Aspects Between Schizophrenia Treatment Approaches: Oral Antipsychotics vs Aripiprazole Long-Acting Injectable.

49 Combinatorial Pharmacogenomics to Guide Treatment Selection for Major Depressive Disorder: A Large, Blinded, Randomized Controlled Trial.

34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities.

Dopamine antagonist antipsychotics in diverted forensic populations.

Pharmacological treatment of violence in schizophrenia.

92 Effects of Smartphone Coaching Intervention on Dietary Intake for Bariatric Surgery Candidates: A Pilot Randomized Controlled Trial.

47 Sustained Functional Recovery and Symptom Remission After Maintenance Treatment with Aripiprazole Once-Monthly for Patients with Bipolar I Disorder.

87 Efficacy Measures in an Open-label Dose-Optimization of an Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.

The following abstracts were presented as posters at the 2018 NEI Congress.

81 Bioequivalence of a Manipulation-Resistant Immediate-Release Amphetamine Sulfate Formulation Compared with Reference Standard.

93 Practical Outpatient Pharmacotherapy for Alcohol Use Disorder.

25 Ventriculoperitoneal Shunt as a Meteorologist: Medtronics Shunt Headaches Vaticinating Climatic Perturbation.

Commentary on: drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs.

61 Heroin Dependence as an Enantiopathy to Quetiapine-Induced Restless Leg Syndrome.

80 Misdiagnosis as a Cause of Treatment Failure in Repetitive Transcranial Magnetic Stimulation Therapy (rTMS) for MDD.

6 Presence and Impact of Possible Tardive Dyskinesia in Patients Prescribed Antipsychotics: Results from the RE-KINECTStudy.

97 My Inner Blizzard: Effect of Weather on Multiple Sclerosis Exacerbation.

Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatment.

39 Long-term Safety and Tolerability of Once-Daily Valbenazine in Patients with Tardive Dyskinesia.

Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder.

Risk of Parkinson’s disease among patients with herpes zoster: a nationwide longitudinal study

Brain metastasis affecting frontal lobe misdiagnosed as bipolar disorder, without any neuroimaging exam: two case reports with fatal outcomes.

Principles and practices of risk assessment in mental health jail diversion programs.

Problematic internet use: an exploration of associations between cognition and COMT rs4818, rs4680 haplotypes.

82 Ice Melts Phantogeusia: Cold Inhibition of Gustatory Hallucinations.

Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with major depressive disorder.

35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia.

40 Pseudo Cranial Nerve I Dysfunction: Subjective Hyposmia and Subjective Hypogeusia but Normosmia and Normogeusia - 3 cases.